MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: Diabetes & Endocrinology
Diabetes & Endocrinology

Substituting Water for Artificially Sweetened Beverages Fails to Improve Glycemic Control in Type 2 Diabetes: Results from the SODAS Trial

MedXY Editorial TeamFeb 2, 2026
Glycemic Controltype 2 diabetes

Highlights

  • Replacing artificially sweetened beverages (ASBs) with water did not lead to improvements in glycemic control over 24 weeks in adults with type 2 diabetes.
  • The water-substitution arm showed a statistically significant 0.29% higher HbA1c compared to the group that continued ASB consumption.
  • No significant differences were observed in secondary measures such as body weight, fasting insulin, or continuous glucose monitor metrics.
  • The findings challenge the clinical assumption that water is always a superior substitute for ASBs in the context of diabetes management.

Introduction: The Sweetener Dilemma in Diabetes Management

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Enhancing Glycemic Control in Non-Insulin-Treated Type 2 Diabetes with Continuous Glucose Monitoring: New Evidence from the CONNECT Trial

Diabetes & EndocrinologyOct 24, 2026

Retatrutide: A Breakthrough Triple Agonist for Obesity and Type 2 Diabetes Management

Diabetes & EndocrinologyOct 15, 2026

Acmopatide Shows Promising Glycemic and Weight Control in Overweight Adults with Type 1 Diabetes: Phase 2 Trial Results

Diabetes & EndocrinologyNov 4, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story